{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:22:07Z","timestamp":1778815327346,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.semarthrit.2016.10.002","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T15:35:03Z","timestamp":1476632103000},"page":"609-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6727-1273","authenticated-orcid":false,"given":"Francesca","family":"Ingegnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Castrejon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.10.002_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrrheum.2015.116","article-title":"Patient-reported outcomes in core domain sets for rheumatic diseases","volume":"11","author":"van Tuyl","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/ard.2007.078923","article-title":"Development of a provisional core set of response measures for clinical trials of systemic sclerosis","volume":"67","author":"Khanna","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib3","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3899\/jrheum.090372","article-title":"Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)","volume":"36","author":"Khanna","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib4","first-page":"501","article-title":"Outcome measurements in scleroderma: results from a delphi exercise","volume":"34","author":"Gazi","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib5","first-page":"1630","article-title":"Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6","volume":"30","author":"Merkel","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/annrheumdis-2014-206485","article-title":"The EULAR Outcome Measures Library: an evolutional database of validated patient-reported instruments","volume":"74","author":"Castrejon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib7","first-page":"910","article-title":"The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments","volume":"33","author":"Castrejon","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"Mokkink","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib9","first-page":"1718","article-title":"Disease and symptom burden in systemic sclerosis: a patient perspective","volume":"34","author":"Suarez-Almazor","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib10","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3899\/jrheum.090504","article-title":"The symptom burden index: development and initial findings from use with patients with systemic sclerosis","volume":"37","author":"Kallen","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jbspin.2007.06.014","article-title":"Indices of the Scleroderma Assessment Questionnaire (SAQ) can be used to demonstrate change in patients with systemic sclerosis over time","volume":"75","author":"Ostojic","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00393-006-0050-7","article-title":"The Scleroderma Assessment Questionnaire (SAQ). A new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis","volume":"65","author":"Ostojic","year":"2006","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/rheumatology\/kel432","article-title":"Using a self-reported functional score to assess disease progression in systemic sclerosis","volume":"46","author":"Serednicka","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib14","first-page":"79","article-title":"Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument","volume":"25","author":"Silman","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib15","first-page":"292","article-title":"Lack of relationship between functional ability and skin score in patients with systemic sclerosis","volume":"28","author":"Herrick","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/keg145","article-title":"A cross-sectional comparison of three self-reported functional indices in scleroderma","volume":"42","author":"Smyth","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/ard.2009.107706","article-title":"The minimally important difference and patient acceptable symptom state for the Raynaud\u2019s condition score in patients with Raynaud\u2019s phenomenon in a large randomised controlled clinical trial","volume":"69","author":"Khanna","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/acr.21858","article-title":"Evaluation of test characteristics for outcome measures used in Raynaud\u2019s phenomenon clinical trials","volume":"65","author":"Gladue","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib19","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I","article-title":"Oral iloprost treatment in patients with Raynaud\u2019s phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study","volume":"41","author":"Wigley","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib21","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1007\/s00296-011-2049-x","article-title":"The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients","volume":"32","author":"Maddali Bongi","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib22","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/ard.2007.070532","article-title":"Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale","volume":"66","author":"Mouthon","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib23","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10067-013-2321-4","article-title":"Translation, cross-cultural adaptation, and validation of the Mouth Handicap in Systemic Sclerosis questionnaire (MHISS) into the Dutch language","volume":"32","author":"Schouffoer","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib24","first-page":"S15","article-title":"Development and validation of French version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"29","author":"Bae","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib25","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3899\/jrheum.110060","article-title":"Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis","volume":"38","author":"Baron","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib26","first-page":"S61","article-title":"A Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"33","author":"Gorga","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib27","first-page":"S55","article-title":"Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis","volume":"33","author":"Gualtierotti","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib28","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib29","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3899\/jrheum.110225","article-title":"Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"38","author":"Khanna","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib30","first-page":"S-41","article-title":"Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch","volume":"32","author":"Meijs","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/ken490","article-title":"Establishment and partial validation of a patient skin self-assessment questionnaire in systemic sclerosis","volume":"48","author":"Nagy","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/rheumatology\/38.6.535","article-title":"Development and validation of a self-administered systemic sclerosis questionnaire (SySQ)","volume":"38","author":"Ruof","year":"1999","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.semarthrit.2016.10.002_bib33","first-page":"332","article-title":"Measuring disability of women with systemic sclerosis: validation of the italian version of the systemic sclerosis questionnaire","volume":"151","author":"Uras","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rbr.2014.03.003","article-title":"Translation, cultural adaptation and validation into portuguese (Brazil) in Systemic Sclerosis Questionnaire (SySQ)","volume":"54","author":"Machado","year":"2014","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib35","first-page":"754","article-title":"Treatment of scleroderma","volume":"134","author":"Guillevin","year":"1983","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib36","first-page":"S50","article-title":"Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis","volume":"30","author":"Castrejon","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.002_bib37","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","article-title":"The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"}],"updated-by":[{"DOI":"10.1016\/j.semarthrit.2017.06.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000}}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216303432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216303432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:56:44Z","timestamp":1758733004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216303432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0049017216303432"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.10.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}